Sankala Group’s Merck MRK Stock Holding History

Sankala Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$33.6K	Hold	231	–	–	0.02%	277
2026 Q2	$31.3K	Buy	231 +2	+0.9%	+$234	0.02%	297
2026 Q1	$27.7K	Hold	229	–	–	0.02%	288
2025 Q4	$28.4K	Buy	+229	New	+$21.5K	0.02%	281

Other funds holding MRK

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Sankala Group's MRK Position: Q3 2026 in Review

Sankala Group held its Merck (MRK) position steady in Q3 2026 at 231 shares worth $33.6K. The position accounts for 0.02% of the portfolio, ranked #277.

Sankala Group first reported a position in MRK in Q4 2025 and has held it in 4 quarters since. 2,825 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

Sankala Group held 231 shares of Merck worth $33.6K as of Q3 2026.
Sankala Group left its Merck share count unchanged in Q3 2026.
Merck made up 0.02% of Sankala Group's portfolio in Q3 2026, its #277 holding.
Sankala Group first reported a position in Merck in Q4 2025 and has held it in 4 quarters since.
2,825 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Sankala Group's 13F filing for Q3 2026, filed 9 Nov 2026.